Results 61 to 70 of about 579,519 (167)

Long‐Term Prognosis and Immunotranscriptomic Landscape in Esophageal Squamous Cell Carcinoma With Different Pathological Responses to Neoadjuvant Chemoradiotherapy: A Retrospective Cohort Study

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
This study comprehensively characterizes the long‐term prognosis and immunotranscriptomic landscape associated with different tumor regression grades (TRGs) in esophageal squamous cell carcinoma (ESCC) following neoadjuvant chemoradiotherapy. By integrating bulk RNA‐seq, single‐cell transcriptomics, and multiplexed immunohistochemistry, we demonstrate ...
Jianye Yuan   +13 more
wiley   +1 more source

Management of metastatic esophagogastric junction adenocarcinoma

open access: yes, 2018
The prognosis of metastatic disease of esophagogastric junction adenocarcinoma remains poor, despite using a variety of regimens using cytotoxic agents.
Imamura, Yu   +3 more
core  

Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction

open access: yes, 2018
STUDY DESIGN AND PURPOSE: Positron emission tomography (PET)/magnetic resonance imaging (MRI) is a new modality that has showed promising results for various clinical indications.
Johannesen, Helle Hjorth   +13 more
core   +1 more source

Advances in therapeutic approaches to gastric cancer

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 5, September/October 2026.
Abstract Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with nearly 1 million new cases diagnosed annually. Despite innovations in diagnosis, most patients still present at advanced stages, contributing to a poor prognosis.
Feng Wang   +9 more
wiley   +1 more source

Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction

open access: yes, 2019
To facilitate the initial clinical decision regarding whether to use esophagectomy alone or neoadjuvant therapy in surgical care for individual patients with adenocarcinoma of the esophagus and esophagogastric junction—information not available from ...
Lu, Min   +7 more
core   +1 more source

The Contribution of the Left Phrenic Nerve to Innervation of the Esophagogastric Junction [PDF]

open access: yes, 2020
The contribution of the left phrenic nerve to innervation of the esophagogastric junction. The esophagogastric junction is part of the barrier preventing gastroesophageal reflux.
Djonov, Valentin   +14 more
core   +2 more sources

Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction

open access: yesCancer Management and Research, 2020
Jiadi Xing,* Maoxing Liu,* Kai Xu,* Pin Gao, Fei Tan, Zhendan Yao, Nan Zhang, Hong Yang, Chenghai Zhang, Ming Cui, Xiangqian Su Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV,
Xing J   +10 more
doaj  

Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori

open access: yesCase Reports in Gastroenterology, 2011
A 75-year-old man underwent endoscopic hemostatic therapy for hemorrhagic gastric ulcer in September 2002. After healing of the gastric ulcer, he underwent Helicobacter pylori eradication therapy in February 2003.
Yasuhiko Abe   +7 more
doaj   +1 more source

Long-Term Results with Surgery Alone and Multimodal Treatments

open access: yes, 2017
Esophagogastric junction (EGJ) adenocarcinoma survival improved recently, thanks to the use of multimodal treatments. Survival with surgery alone is instead still poor in all locally advanced and node-positive patients. Recurrence is still the main cause
Weindelmayer, Jacopo   +9 more
core   +1 more source

Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction

open access: yesOpen Medicine, 2016
The TGF-β/SMAD signaling pathway is found to play pivotal roles in cell growth, differentiation and tumorigenesis. Its target genes are closely related to the biological behaviors of some malignancies.
Peng Defeng, Fu Lin, Sun Guoping
doaj   +1 more source

Home - About - Disclaimer - Privacy